Table 1.
|
First primary |
Second primary |
||
---|---|---|---|---|
N (52,103) | % | n (4457) | % | |
Sex | ||||
Male | 12,875 | 24.71% | 1518 | 34.06% |
Female | 39,228 | 75.29% | 2939 | 65.94% |
Race/ethnicity | ||||
Black | 2932 | 5.63% | 272 | 6.10% |
White | 43,045 | 82.62% | 3799 | 85.24% |
Other | 5717 | 10.97% | 384 | 8.62% |
Unknown | 409 | 0.78% | 2 | 0.04% |
Age at diagnosis (years) | ||||
<40 | 19,539 | 37.50% | 794 | 17.81% |
40–49 | 11,653 | 22.37% | 959 | 21.52% |
50–59 | 9408 | 18.06% | 1085 | 24.34% |
60–69 | 6211 | 11.92% | 1009 | 22.64% |
70+ | 5292 | 10.16% | 610 | 13.69% |
Year of diagnosis | ||||
1973–1983 | 8978 | 17.23% | 1612 | 36.17% |
1984–1993 | 10,983 | 21.08% | 1375 | 30.85% |
1994–2003 | 17,745 | 34.06% | 1192 | 26.74% |
2004–2008 | 14,397 | 27.63% | 278 | 6.24% |
Histology | ||||
Papillary | 41,989 | 83.66% | — | — |
Follicular | 6438 | 12.83% | — | — |
Medullary | 1314 | 2.62% | — | — |
Anaplastic/other | 450 | 0.90% | — | — |
Tumor size | ||||
0–10 mm | 11,356 | 21.80% | 672 | 15.08% |
11–20 mm | 9981 | 19.16% | 501 | 11.24% |
21–50 mm | 11,018 | 21.15% | 624 | 14.00% |
>51 mm | 6737 | 12.93% | 493 | 11.06% |
N/A | 13,011 | 24.97% | 2167 | 48.62% |
Radiation treatment | ||||
None | 29,376 | 58.39% | 2814 | 63.35% |
Beam radiation | 2019 | 4.01% | 201 | 4.52% |
Isotopes | 16,602 | 33.00% | 934 | 21.03% |
Radiation, NOS | 130 | 0.26% | 423 | 9.52% |
Other | 2182 | 4.34% | 70 | 1.58% |
N/A, not available; NOS, not otherwise specified.